Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

<ul><li> Excessive levels of platelet-derived EVs have been implicated in many diseases and AEMD is developing a pipeline of indications for the device leveraging highly cost efficient steps.</li><li>To-date, 173 Hemopurifier treatments have been administered in 44 patients with no serious adverse events (SAEs).</li><li>Cash & equivalents at YE 2025 were ~$7.0m.</li></ul>

 Excessive levels of platelet-derived EVs have been implicated in many diseases and AEMD is developing a pipeline of indications for the device leveraging highly cost efficient steps.To-date, 173 Hemopurifier treatments have been administered in 44 patients with no serious adverse events (SAEs).Cash & equivalents at YE 2025 were ~$7.0m.

血小板由来EVの過剰なレベルは多くの疾患に関与していることが示唆されており、AEMD社は非常に費用対効果の高い手順を活用しながら、このデバイスの適応症のパイプラインを開発している。

Aethlon Medical

血小板由来EVの過剰なレベルは多くの疾患に関与していることが示唆されており、AEMD社は非常に費用対効果の高い手順を活用しながら、このデバイスの適応症のパイプラインを開発している。